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Introduction
Women with polycystic ovary syndrome (PCOS) are at increased risk of adverse pregnancy outcomes such as gestational diabetes mellitus (GDM), preterm delivery and preeclampsia in singleton pregnancies (1) (2) (3) . The association between PCOS and adverse pregnancy outcome is controversial, but the risk seems related to maternal prepregnancy concentrations of androgens, indicating that the severity of the prepregnancy endocrine disturbances is of significance (4) . However, the precise association is difficult to establish, because women with PCOS more often require assisted reproductive technology (ART) compared with women without the disorder (1) . ART has been associated with several types of adverse pregnancy outcome in singletons, but whether this is a result of the mode of conception or of parental characteristics is still debated (5) . ART increases the risk of twin pregnancies, which, irrespective of mode of conception, are associated with an increased risk of pregnancy and delivery complications similar to those of women with PCOS in singleton pregnancies (6) (7) (8) .
In consequence we hypothesized that women with PCOS and a twin pregnancy after ART have increased risk of adverse pregnancy complications compared with twin pregnancies in women without PCOS.
A recent Nordic register study by Løvvik et al. found that women with PCOS and twin pregnancies have an increased risk of preterm delivery (9) . Though it comprised a large sample size, this study was not able to adjust for important factors such as mode of conception and maternal androgen level. Furthermore, the study did not take chorionicity into account. In twin pregnancies the risk of adverse outcome is closely related to chorionicity, and is much larger in monochorionic compared with dichorionic twins (10, 11) .
The aim of this study was to compare pregnancy outcome in dichorionic twin pregnancies of women with and without PCOS and to relate the outcome to maternal androgen levels of women with PCOS.
Material and methods
The study consists of a group of women, diagnosed with PCOS at a private fertility clinic, Trianglen in Copenhagen, who delivered twins at public hospitals in Denmark between 1997 and 2010. All original patient files were reviewed to confirm that the Rotterdam criteria from 2004 were used to diagnose PCOS (12) . The Rotterdam criteria require at least two of the following three criteria to be met: anovulation, polycystic ovaries and hyperandrogenism. Due to the increased overall risk of obstetrical complications in monochorionic pregnancies inclusion was restricted to women with a dichorionic twin pregnancy and delivery after gestational week 22 (10, 11) . Chorionicity has been determined at the first-trimester nuchal scan since 2004 in Denmark. In pregnancies before 2004 information on chorionicity was retrieved from the original clinic and hospital files when possible, and pregnancies of unknown chorionicity were excluded.
The comparison group comprised all dichorionic twin deliveries from 2005 to 2007 at Hvidovre University Hospital, the largest obstetrical department in the capital region with a total of 5433 deliveries in 2005. All patient files were retrospectively reviewed to exclude twin pregnancies in women with a PCOS diagnosis, twin pregnancies resulting from fetal reduction in a triplet pregnancy, and women diagnosed with diabetes before the actual pregnancy. For both groups the method of conception was extracted from patient files and registered as either spontaneous, or preceded by intrauterine insemination (IUI) (including ovulation induction), in vitro fertilization (IVF), or intracytoplasmic sperm injection (ICSI), including frozen embryo replacement.
Data on maternal and perinatal outcomes from all pregnancies were retrieved from the Danish Medical Birth Register and the Danish National Patient Register using each woman's unique personal identification number (13) . The registries include information about all liveborn children and stillbirths after 22 weeks of gestation and all pregnancy-and delivery-related diagnoses using the International Classification of Diseases 10th revision. Data regarding the women [maternal age, parity, prepregnancy body mass index (BMI) and smoking habits (categorized as smoker/non-smoker], the pregnancy (preeclampsia, GDM, cesarean section and induction of labor), and the delivery (birthweight, gender, gestational age, Apgar score at 5 min and perinatal death) were extracted.
The women were defined as being overweight if their BMI was > 25 kg/m 2 . Further stratification of BMI into categories was not possible because of the relatively small size of our sample. Preeclampsia was, in Denmark throughout the time period of interest, defined as presence of proteinuria and a blood pressure > 140/ 90 mmHg. GDM was defined as plasma intravenous glucose level > 9.0 mmol/L after a 75-g 2-h oral glucose tolerance test. However, screening for GDM was not systematically performed in all twin pregnancies throughout the study period. Preterm delivery was defined as birth before gestational week 37 and further sub-classified as very preterm (gestational age between 28 and 32 weeks) and extremely preterm (gestational age < 28 weeks) (14) . Birthweight was classified according the World Health Organization into: low birthweight 1500-2500 g, very low birthweight 1000-1500 g, and extremely low birthweight < 1000 g (15) . Small-for-gestational-age was defined as gestational age and gender adjusted birthweight less than À 22% (16) .
During the study period, all measurements of androgens in Denmark were performed at the Statens Serum Institut (SSI), Copenhagen. Using the Danish personal identification number of each woman, all androgen measurements in the PCOS population obtained before fertility treatment and pregnancy were retrieved from the SSI. These measurements included total testosterone measured by radioimmunoassay, sex hormone-binding globulin measured by immunofluorescence, and estimation of the free testosterone concentration (17) . The intra-assay and inter-assay variations were 8.2 and 13.8%, respectively, for testosterone and 5.2 and 7.5%, for sex hormone-binding globulin.
A woman from the PCOS group was considered hyperandrogenic if total testosterone and/or free testosterone exceeded the upper limit of the normal range for premenopausal women: 1.8 and 0.034 nmol/L, respectively. In cases with several measurements of androgens, we chose the androgens measured at the date closest to the twin pregnancy. Androgen measurements were not available in all women with PCOS; furthermore, no androgen measurements were available for the comparison group.
Statistical analyses
Demographic data are presented by raw numbers, frequencies or means with standard deviation (SD) according to variable character, and the distribution of data was tested by histogram plotting. The two groups (PCOS group and the comparison group) were compared by an unpaired two-sample Student's t-test. Discordance of twin birthweight was calculated as the difference in birthweight between the twins divided by the weight of the larger twin. The number is expressed in percentages and a discordance > 20% was regarded as severe discordance indicating insufficient intrauterine growth. Multivariable logistic regression was used to investigate the relationship between each outcome [pre-eclampsia, GDM, preterm delivery (< 37 weeks of gestation) and low birthweight (<2500 g)], and the following possible risk factors; PCOS (present or not), method of conception (spontaneous, IVF/ICSI or IUI), overweight (prepregnancy BMI > 25 kg/m 2 present or not), parity (nulliparous or multiparous), smoking (yes or no). For each outcome, a separate model was analyzed using all explanatory variables also including hyperandrogenism (yes/no).
A p value < 0.05 was considered significant. Statistical analysis was performed using SPSS version 20 software package (IBM Corp., Armonk, NY, USA).
Ethical approval
The study was approved by The Danish Data Protection Agency (2011-41-6645) and the Danish National Board of Health (3-3013-43/1) on 13 February 2012.
Results
A total of 391 dichorionic twin pregnancies were identified. Of these, 91 women had PCOS and were treated at the fertility clinic, while 300 women constituted the group for comparison. A total of 19 sets of twins were excluded from the PCOS group because of: reduction of multiples to twins (n = 10), unknown chorionicity (n = 7) and intrauterine death of one twin (n = 2), From the comparison group a total of 12 sets of twins were excluded: women with a hospital PCOS diagnosis before the present pregnancy (n = 10), reduction of multiples to twins (n = 1), and intrauterine death of one twin (n = 1). Analyses were performed on the remaining 72 women with PCOS and 288 women without PCOS.
Completeness of data was 100% with respect to maternal age, parity, gestational age, preeclampsia, cesarean section, induction of labor and neonatal outcome. Data on BMI were 67 and 98% complete in the PCOS and comparison groups, respectively. Data on smoking habits and method of conception were complete in more than 93% of both groups.
The women in the two groups were comparable regarding age, parity and smoking habits ( Data on perinatal outcome (Table 2) were based on the number of twins (144 in the PCOS group and 576 in the group without PCOS). There was no difference in the risk of preterm delivery between the two groups. However, we observed five (5/144) cases of delivery before gestational week 28 in the women with PCOS compared with two cases (2/576) in the comparison group. Of the five women with PCOS, two had been treated by IUI, one by IVF, one by ICSI, and one conceived spontaneously between treatments whereas the two cases in the comparison group had both received ART (IVF or IUI). The logistic regression model revealed that only smoking (regression coefficient B = 1.48, p < 0.000 and OR 4.39, 95% CI 2.08-9.24) and parity (regression coefficient B = -0.95, p < 0.000 and OR 0.38, 95% CI 0.27-0.55) were independently associated with preterm delivery. and/or method of conception) was associated with the risk of low birthweight.
There was no significant difference in the risk of the pregnancy complications preeclampsia (8.3% vs. 6.6%, p = 0.6) and GDM (1.4% vs. 1.7%, p = 0.8) between women in the two groups. In the logistic regression analysis, the method of conception was a risk factor for preeclampsia (p = 0.009) with an OR of 2.17 (95% CI 1.07-4.40) in IVF/ICSI pregnancies compared with spontaneous dichorionic twin pregnancies, whereas there was no significant impact from a PCOS diagnosis (p = 0.58), smoking (p = 0.38), multiparity (p = 0.55) or overweight (p = 0.71). BMI was the only independent variable associated with the risk of GDM (p = 0.019, OR 7.3, 95% CI 1.38-38.98).
Delivery by cesarean section (50.0% vs. 63.1%, p = 0.04) and induction of labor (19.4% vs. 37.7%, p = 0.04) were significantly less frequent in the PCOS group compared with the background population women without PCOS.
Maternal prepregnancy androgen measurements were available in 65.3% (n = 47) of the women in the PCOS group, and 61.7% (n = 29) were hyperandrogenic and 38.3% (n = 18) were normoandrogenic (Table 3) . Eight women in the PCOS group were both hyperandrogenic and hirsute, and all had ovarian PCOS morphology. Eight of the women in the PCOS group had regular menstrual cycles but were hyperandrogenic, whereas the remaining 66 all experienced oligo-/anovulation.
The risk of maternal pregnancy complications and the neonatal outcomes were similar in hyperandrogenic and normoandrogenic women with PCOS (Table 3) . 
Discussion
Overall, we found only small differences in the pregnancy outcome and pregnancy complications in dichorionic twin pregnancies in women of normal weight with and without PCOS. Furthermore, the pregnancy outcome was unrelated to the maternal prepregnancy androgen levels, indicating that the outcome of dichorionic twin pregnancies is neither associated with a maternal PCOS diagnosis nor affected by the severity of the PCOS. There appears to be no association with hyperandrogenism and twin pregnancy outcomes in women with PCOS; however, data on biochemical hyperandrogenism was only available in 65% of cases. This is in contrast to the increased risk of pregnancyrelated disorders such as GDM, preeclampsia, preterm delivery and intrauterine growth retardation described in singleton pregnancies in women with PCOS (2, (18) (19) (20) . Most of these studies address populations of women with a PCOS diagnosis and take neither plurality nor mode of conception into account. However, controlling for mode of conception has shown that the risk of adverse pregnancy outcome in singleton pregnancies is related to the prepregnancy maternal androgen levels (4). This indicates that the pregnancy outcome is related to the severity of the PCOS condition. However, five (5/144) of the women with PCOS delivered before gestational week 28 compared with two (2/576) in the comparison group. The difference in the risk of extreme preterm twin delivery between the groups could be related to the PCOS condition or the mode of conception, but may also be a random finding, as a causative relationship would require a dose-response relationship, and we found no increased risk of preterm and early preterm delivery. However, the Swedish population-based study including 225 women with twin pregnancies and PCOS reported an increased risk of preterm and extremely preterm delivery in women with PCOS with ORs of 1.18 and 1.64, respectively (9), but included both monochorionic and dichorionic pregnancies. Neither the Swedish nor the present study indicate an increased risk of other adverse pregnancy outcomes in twin pregnancies in women with PCOS. The different finding in singleton and twin pregnancies supports the theory that factors affecting pregnancy duration are different in singleton and multiple pregnancies (21) .
Investigating pregnancy outcome in women with PCOS is associated with several challenges: change of the diagnostic criteria for PCOS during the time period, the impact of fertility treatment on pregnancy outcome, and selection of an appropriate group for comparison. To minimize these challenges, we reviewed all original files to confirm that all PCOS cases fulfilled the Rotterdam criteria. Ten of the 300 women (3.3%) from the background population were excluded due to a previous PCOS diagnosis identified on review of the patient files compared with 223 cases of PCOS in 20.965 women (1%) in the Swedish study (9) . As the prevalence of PCOS is estimated to be in the order of 5-15%, we expect that several women with PCOS are undiagnosed, which may underestimate the risks associated with PCOS. Infertility treatment, both ovulation induction and IVF (with or without ICSI), is associated with increased risk of adverse pregnancy outcome (8) , and even if we controlled for such factors by logistic regression, some residual confounding may not be addressed. The use of frozen embryo replacement in the PCOS group (five cases) and not in the comparison group could lead to a better outcome in the PCOS group but not a significant difference.
We chose to address women with PCOS at a private fertility clinic with special interest in PCOS and were able to identify pretreatment androgen measurements in 65% of the patients. These measurements were all performed at the same national laboratory, making comparisons between hyperandrogenic and normoandrogenic women possible. PCOS was diagnosed in the infertile women according to the later published Rotterdam criteria, and the androgens were not measured in all women, which might affect the results. In our study, the women with PCOS did not have a higher BMI than the comparison group, which may reflect a higher socioeconomic status and possibly a healthier lifestyle in women seeking private fertility treatment, although fertility treatment is generally free of charge in Denmark.
The strength of this study is our method of patient selection. The Danish National registers are a unique resource and allowed us to collect detailed information on a relatively large group of dichorionic pregnancies and adjust for mode of fertility treatment. All women had comparable antenatal care and delivery at public hospitals in the catchment area. The maternal and perinatal outcomes were retrieved from the Danish national registers and validated manually. We also excluded women with a PCOS diagnosis from the comparison group, but we expect that several women with PCOS were not diagnosed, which is a general problem in retrospective studies on PCOS.
The retrospective design of the study with cases identified during a 14-year period has severe limitations, and not all potential confounders were described in all women. The comparison group was identified in a 3-year period, which can be a cause of bias. Prepregnancy BMI was available in only 68% of the PCOS group compared with 97% in the comparison group, and screening for GDM was not performed systematically. The study has a relatively small sample size, which reduces the statistical power and leads to our cautious conclusion. Some of the limitations could probably be omitted if both PCOS and non-PCOS women were studied throughout the same time period and both selected from the same public hospital. However, this would result in few women with PCOS because they are rare.
In conclusion, a PCOS diagnosis does not seem to increase the overall risk of adverse pregnancy outcomes such as preeclampsia and growth retardation in dichorionic pregnancies, but a possible impact of a PCOS diagnosis on the risk of preterm delivery in dichorionic twins cannot be ruled out, and calls for prospective studies.
